Edward Penley Abraham (Ted Abraham to intimate friends and family, EPA to his students), was a pioneer in antibiotics who made critical contributions to the purification and structural elucidation of penicillin as a young man in wartime, and led the discovery and development of cephalosporin C in his maturity. A kindly, modest and self-effacing private man, he could have amassed great wealth out of cephalosporin patents, but instead chose the path of philanthropy. He established substantial charitable funds in his lifetime for the benefit of medicine and allied subjects, the Royal Society, King Edward VI School, Southampton, and the University of Oxford, especially the Sir William Dunn School of Pathology and Lincoln College.
early life
Abraham was born on 10 June 1913 at 47 South View Road, Southampton, which now sports a commemorative blue plaque. His parents were Albert Penley Abraham, a customs and excise officer, and Maria Agnes Abraham, née Hearne, who was born in Ireland, daughter of a journeyman carpenter. His only sibling, Mary Abraham, was born in 1917. Abraham's paternal family had deep roots in the Southampton area, traceable to the John Abraham who married Mary Heckley at Alverstoke in 1765, and perhaps beyond. The persistent given name Penley came into the family through Elizabeth Penley of St Pancras, who married William Burree there in 1826: she was the paternal grandmother of Abraham's paternal grandmother.
In 1924 Abraham entered King Edward VI School, Southampton (KES), with a Corporation Scholarship, and showed sporting prowess and academic talent right across the board. The heads of both classics and science solicited him to specialize, and the direction he took was a close-run thing, although late in life, typically modest and unconvincing, he said he would have been no good at classics. He was admitted to The Queen's College, University of Oxford Asbjørg was reluctant to leave Norway in haste, and in April 1940 she was trapped there by the Nazi invasion, after which they could only communicate surreptitiously via Erdtman in neutral Sweden. His last surviving letter to her, in January 1941, shows mutual resignation to more years of separation and concluded 'I try to wait for you with courage'. She escaped on foot over the mountains to Sweden later that year, and was still in Stockholm in mid-1942, but she somehow managed to turn up unannounced at Abraham's parents' house during the blackout, soon after entering the UK at Aberdeen in November. Their only child, Michael Erling Penley Abraham, born in Oxford in July 1943, was severely disabled, a sadness of which Abraham hardly ever spoke.
The sTrucTure of penicillin
When Abraham took up his post in the Dunn School, Florey, Chain and Norman Heatley were already engaged on work with several antibacterial preparations, including 'penicillin', which Alexander (later Sir Alexander) Fleming (FRS 1943) had discovered but not foreseen the importance of. It was at that stage a complex mixture, of which the active agent was a potent but minor (much less than 1%) constituent. Florey performed a historic experiment on 25 May 1940 in which he gave eight mice a potentially fatal streptococcal infection and then treated four of them with penicillin: the controls died overnight, but the treated animals were all alive two days later. This was quickly followed by experiments that consolidated the demonstration that penicillin was a potential miracle cure for bacterial infections-if enough of it could be produced. Abraham's name was not on the first Lancet paper (Chain et al. 1940 ) but he was very much involved in its production and purification, his particular contribution being alumina chromatography (6), then a very novel technique, and he was party to the first human toxicity trial on 27 January 1941 (10), telling Asbjørg two days later, 'We are beginning to test our material for possible toxic effects on human patients-choosing those that are bound to die anyhow!' So his name was on the second Lancet paper (5).
As soon as enough material approaching homogeneity became available (6), a great deal of effort was invested secretly on both sides of the Atlantic in discovering the structure of the active substance, in the hope that that could be followed by chemical synthesis. The principal Oxford organic chemists on the case were Abraham and Chain in the Dunn School, and Baker, J. W. (later Sir John) Cornforth (FRS 1953) and Robinson in the DP. All of these made important contributions to what was probably the most complex structural problem in organic chemistry tackled and solved up to that time, with few physical aids to call on. The active substance was labile, of questionable purity to start with, and was to turn out eventually to have a completely novel structure. The work was never published in the usual way, and the results were spread over a large number of secret reports that were summarized at the war's end (Clarke et al. 1949) .
Abraham himself wrote several historical accounts of the penicillin story (10, 32, 43, 45, 47, 48); see also Curtis et al. (2008) , pp. 65-72, and Curtis & Jones (2007) .
Abraham and Chain obtained evidence by September 1942 that acid hydrolysis of penicillin gave an amino acid. Abraham isolated this amino acid, which was named penicillamine, in crystalline form as a hydrochloride. A great leap forward might have been made at this stage if it had been realized that the transient deep blue colour seen on oxidation of penicillamine with ferric chloride was like the characteristic blue seen on the oxidation of cysteine with the same reagent. This was not considered because the analysts had not found any sulphur in penicillin.
Oxidation with bromine water gave a strong dibasic acid, penicillaminic acid, which was formulated in ignorance of the presence of sulphur as C 5 H 11 O 7 N. Abraham also managed to form a stable crystalline copper salt that seemed to be [C 5 H 10 O 7 N] 2 Cu. In an attempt to explain the high oxygen content it had been suggested that it was hydrated, but it did not release water when strongly heated over a drying agent in vacuo.
Baker, now convinced that there had been an analytical oversight, performed a sodium fusion test on a sample of penicillamine hydrochloride in July 1943, and obtained a positive result for sulphur. Up to this point the Oxford team had been working with penicillin as its amorphous but convenient barium salt, which was the origin of the analytical mistake, the sulphur having been lost as insoluble barium sulphate (J. W. Cornforth, personal communication reported in Curtis et al. (2008) , p. 66). On hearing that the sodium salt of American penicillin (see scheme 1) had been crystallized, Abraham made the sodium salt of the Oxford penicillin, which crystallized easily. These findings removed much confusion, and rapid progress followed. Abraham proved that penicillamine was an α-amino-β-mercapto acid, and obtained a crystalline thiazolidine when attempting to recrystallize it from hot acetone. Cornforth then guessed the presence of a gem-dimethyl group, and proved by synthesis that penicillamine was in fact β,β-dimethylcysteine (= β-mercaptovaline).
In addition to penicillamine, acid hydrolysis of penicillin gave CO 2 and an acylaminoacetaldehyde. Robinson deduced that the CO 2 had resulted from decarboxylation of the corresponding α-carboxy aldehyde, and that penicillin (the correct molecular formula of which was by then known) could be notionally reconstructed from penicillamine by thiazolidine formation between it and the α-carboxy aldehyde, followed by dehydration, and proposed a thiazolidineoxazolone structure. Abraham, however, had been engaged in performing electrometric titrations on penicillin and was unable to find evidence of a weakly basic group, such as the thiazol idine nitrogen in Robinson's proposed structure. With this in mind he wrote down the isomeric β-lactam structure and showed it to Chain, who received it with enthusiasm. Baker also gave it his support and it was added, in Robinson's absence, to a report that Robinson had drafted. The report (7) was submitted for circulation on 22 October 1943. Robinson was furious, on his return, to discover the amendments made to the final version, going so far as to send in an addendum stating that 'one of us considers the four ring structure above somewhat improbable.' Scheme 1. The notional reconstruction of penicillin from its degradation products. R = pent-2-enyl for the penicillin grown by fermentation in Oxford; R = benzyl for that grown in America. The difference was slightly confusing until clarified in 1943, but it did not affect the structural debates.
Robinson was a genius who was rarely wrong, but over penicillin he was blinkered by his own self-confidence. Even when Abraham's structure was proved crystallographically by Dorothy Hodgkin (FRS 1947) in 1945 (Crowfoot et al. 1949) , he clutched at straws, supposing that the crystal structure did not preclude mobile equilibria with other structures in solution. On the other side of the Atlantic, some, including R. B. Woodward (ForMemFRS 1956 ) strongly supported Abraham's structure, but others favoured Robinson's until the crystal structure proof. An essentially American view of the history of penicillin by J. C. Sheehan was published in 1982. Abraham contributed a handsome foreword (42) to it, with the gentle closing caveat 'He will scarcely expect that all those who read his book will purr with approval of the contents of every page, for on some topics there may never be a final word.'
The discovery, sTrucTure and developmenT of cephalosporin c
In the immediate postwar years Abraham worked on several antibiotic topics and made a visit to Berkeley, where he was introduced to isotopic labelling techniques and contributed to elucidating the mammalian pathway by which tryptophan is converted to nicotinic acid (9). Two things crucial to his later work happened when he returned to Oxford in 1948. Guy Newton was admitted by Florey to the Dunn School for doctoral work, and Giuseppe Brotzu sent Florey a Cephalosporium acremonium culture with antibiotic properties that he had obtained from a sewage outfall in the Bay of Naples.
Abraham himself put modest accounts of the early work on cephalosporin on record a number of times (47, 48), always stressing the joint nature of his collaboration with Newton, which began as that of master and apprentice, but evolved into a partnership of close friends. Florey placed Newton under Abraham's immediate supervision and asked Heatley to make preliminary investigations of Brotzu's antibiotic material, which was shown to be a complex mixture (scheme 2). Larger amounts of it were made in collaboration with the Medical Research Council (MRC) Antibiotics Station at Clevedon in Somerset. It was then passed to Abraham, who investigated the hydrophobic fraction first. The principal component cephalosporin P 1 (P for Gram-positive activity) appeared to have the formula C 32 H 48 O 8 and was closely related to the known antibiotic helvolic acid (16). When Newton had finished his DPhil work he stayed with Abraham to work on the hydrophilic fraction. The major component of that fraction, cephalosporin N (N for Gram-negative activity), was recognized as probably of the penicillin type, and was therefore judged to be worth exploring in depth. The compound responsible for the activity observed by Brotzu, it did eventually turn out to be a new penicillin, and was renamed penicillin N (10, 13, 14). However, its purification was difficult. In September 1953, with a view to obtaining a more easily purified and characterized derivative, Abraham suggested converting the crude cephalosporin N to the corresponding crude penillic acid by mild acid treatment, which is a general isomerization of penicillins, and purifying the product. When Newton performed this experiment, he was indeed able to isolate the penillic acid pure by ion-exchange chromatography, but he did not stop the column, and in the later fractions he found a minor ninhydrin-reactive component with a λ max of 260 nm that had come through from the crude antibiotic mixture unchanged by the acid treatment. It was found to have some similarities in chemical properties to the penicillins, but also some marked differences; and it had a broad spectrum of relatively low antibiotic activity but was resistant to penicillinase. This compound, which was also later isolated with difficulty from the original antibiotic mixture, crystallized easily as a sodium salt. It was arbitrarily named cephalosporin C (15, 17).
The inactivity of penicillinase against cephalosporin C was of importance, because bacterial strains causing infections that did not respond to penicillin therapy were evolving and becoming problematic. Further investigation was therefore undertaken, with strong encouragement from Florey, who did the first in vivo experiments. He showed it was not toxic to mice, and cured otherwise fatal artificially inflicted streptococcal infections; he reported these results in a lecture delivered on 25 April 1955 (Florey 1955) . He remained closely informed thereafter, but he did not put his name on any of the subsequent cephalosporin papers or patents.
After the war it was felt that British ethical reservations about the decency of taking profit from medical discoveries had allowed the American pharmaceutical industry to barge in and reap the financial benefit. This sparked the Development of Inventions Act 1948 and the foundation of the National Research Development Corporation (NRDC), which had a brief to see that inventions in British universities were protected and commercially developed. In return for assignment of rights to the NRDC by inventors, the NRDC would take on the administrative burden and costs of obtaining and commercializing patents, paying the inventors an agreed share of the royalties.
Steps were taken by the NRDC to obtain patent cover for cephalosporin C, and to stimulate industrial interest as soon as its possible potential was appreciated. Several companies in the pharmaceutical industry were interested at an early stage, but Glaxo Laboratories Ltd was the keenest. They were licensed to produce the antibiotic in cooperation with the Oxford and Clevedon workers. Newton was instrumental in helping Glaxo to get going, and made numerous visits to them; in return, Glaxo produced more than 100 g of pure cephalosporin C for work at Oxford. This gave Glaxo a lead in the cephalosporin business and contributed to the continuation of its rise from being a producer of mundane health products to being a sophisticated international drug company, which is now part of GlaxoSmithKline (Jones 2001) .
Abraham and Newton's cephalosporin C structural analysis depended on the study of degradation products, careful observation and colour reactions, but infrared, ultraviolet and even (30 MHz) NMR spectroscopy, then in its infancy, were also used-it was probably the first application of NMR to an important natural product problem anywhere. What would now call for a few milligrams of pure material and a few days with advanced instrumentation needed multi-gram quantities and took five years.
Abraham conceived the fused β-lactam-dihydrothiazine structure of cephalosporin C while on a skiing holiday in 1958 (48). Asbjørg had inherited a chalet at Gullsteinhovda near Geilo in Norway. The couple generally went there at Easter for skiing and in August for hiking. The chalet had a wonderful view overlooking the Hallingdal valley. He would often sit outside it in quietness looking down the valley, and he remarked several times that it was a place that inspired many good research ideas. However, it was not until around April 1959 that the structure was established to Abraham's satisfaction, with first public disclosure at a meeting in Australia in August 1960 (18). Having been in disagreement with Robinson over the structure of penicillin, and then eventually been proved right, Abraham had a similar experience over the cephalosporin C structure with Woodward. After disclosing his structure in Canberra, Abraham travelled home via America and called on Woodward, who said to him, 'If I had proposed that structure for a compound with that absorption spectrum I would be very unhappy' (48). Full details were published in 1961 (19), followed immediately by Dorothy Hodgkin's X-ray confirmation (Hodgkin & Maslen 1961) . Because Robinson and Woodward were arguably the greatest organic chemists of all time, to have bettered them both in turn was no mean feat.
Abraham and Newton also established in principle that the side chain could be removed, giving 7-aminocephalosporanic acid (7-ACA), and replaced by acyl groups such as phenylacetyl with changes in activity (21); and that the acetoxy group was susceptible to displacement by heterocyclic nucleophiles (20). These observations, which were also patented under the auspices of the NRDC, opened the way for the pharmaceutical industry to produce diverse cephalosporin C analogues (scheme 3) based on the bicyclic nucleus 7-ACA, for which improved manufacture was soon developed (Morin et al. 1962 ). Cephalosporin C itself had a few medical successes, but attention soon shifted to the next generation such as cephalothin and cephaloridine, which were being marketed by Eli Lilly & Co. and Glaxo, respectively, by late 1964. With the essentials defined, and the pharmaceutical companies vigorously engaged, the development of derivatives was largely left to them. Thousands have been made by now, and many are in regular clinical use.
β-LacTamases
With Chain, Abraham observed in 1940 (3) that penicillin preparations (still grossly impure and not chemically characterized) were inactivated enzymically by an extract from penicillinresistant B. coli, and in 1944 (8) he showed that the enzyme worked by opening the β-lactam ring. Testing new antibiotic preparations with penicillinase became standard practice, and was important for recognizing cephalosporin N as a member of the penicillin family.
When cephalosporin C was isolated, its stability to pure penicillinase was the trigger for accelerating work on it, but crude penicillinase preparations from B. cereus did inactivate it, and it was found to be a competitive inhibitor of penicillinase (15, 17) . B. cereus was later shown to produce two crystallizable β-lactamases designated I and II, the latter being a zinc-dependent glycoprotein and the former being carbohydrate-free and zinc-independent. β-Lactamase I hydrolysed benzylpenicillin but not cephalosporin C; β-lactamase II hydrolysed them both. The zinc was found to be bound to histidine (26, 29, 36, 37) . Unravelling the workings of these and related enzymes and the fates of the cephalosporin C degradation products, which were much more complicated than with penicillin (27, 28), were major themes of Abraham's later work.
β-LacTam anTibioTic biosynThesis
Blackboard dissection of the cephalosporin C structure pointed to its biosynthesis somehow from valine, cysteine and α-aminoadipic acid. Abraham confirmed this (22-25) by showing that radioactivity was efficiently and specifically incorporated into it on adding radiolabelled amino acids to a Cephalosporium sp. culture. There was correlation between the amounts of penicillin N and cephalosporin C produced, and it was suggested (23) that they had a common biosynthetic intermediate, α-aminoadipylcysteinylvaline (ACV). It was not so straightforward to put that hypothesis to the test, because when labelled peptides were added to intact cultures, they did not penetrate the cells where antibiotic synthesis took place. However, it was shown in 1976 (35) that l,l,d-ACV (but not its epimers) was incorporated intact by a cell-free system obtained from Cephalosporium acremonium into a penicillin that was actually isopenicillin N (38) (scheme 4), and this was directly observed by NMR in 1980 (40) . Enzymic epimerization of isopenicillin N to penicillin N was published in 1981 (41) . The biotransformation of penicillin N into cephalosporin C (scheme 5) had been established earlier (Kohsaka & Demain 1976) , although this was indirect via desacetoxycephalosporin C (Baldwin et al. 1981) . It was thus possible to map the principal pathways in the formation of the two antibiotic systems by the early 1980s (39) .
Abraham was also able to start probing the mechanisms of the five-membered and sixmembered ring-forming processes, by feeding Cephalosporium acremonium numerous valines with methyl groups that were stereospecifically labelled with 13 C, 2 H or 3 H, or both 2 H and 3 H (33, 34, 44). The valine skeleton was incorporated intact (scheme 6), the pro-S methyl group being the exclusive source of the α-methyl group of penicillin N, so the ring closure there was stereospecific. The same methyl group became the exocyclic methylene of cephalosporin C. By contrast, although conversion of the other methyl group into the endocyclic methylene group of cephalosporin C was correspondingly regiospecific, it was stereochemically random so far as choice between the hydrogen atoms was concerned. This observation and previous literature on peroxide-initiated sulphide rearrangements prompted the suggestion (44) that the ring expansion began by hydrogen abstraction from the β-methyl group to give a primary free radical intermediate with a lifetime enabling free rotation before rearrangement to a tertiary radical (scheme 7). The chemical feasibility of the proposal was later demonstrated in the DP (Baldwin et al. 1987) , where radicals generated from 2β-bromomethylpenicillin analogues by treatment with triphenyltin hydride were shown to lead to the cephalosporin ring system.
Exchanges that soon evolved into a close collaboration on β-lactam biosynthesis between
Abraham at the Dunn School and J. E. (now Sir Jack) Baldwin FRS at the DP had begun when Baldwin was installed in Robinson's chair in 1978, a resumption of the interdepartmental relationship that had been so fruitful under pressure over penicillin during the war. Baldwin had entered the field several years previously, recognizing that β-lactam antibiotic biosynthesis posed fundamental problems in mechanistic organic chemistry, because the transformations involved in generating the ring systems of the penicillins and cephalosporins from a tripeptide, whatever they were, were obviously well beyond current textbook explanations. Indeed, Baldwin-then still at Massachusetts Institute of Technology-and American colleagues had obtained results defining the fate of the valine methyl groups at the same time as Abraham's group in Oxford (Neuss et al. 1973) .
The exquisitely elegant work that ensued was probably due more to Baldwin and his many co-workers in the DP than to Abraham and his much smaller Dunn School group, although Abraham's name is on many joint papers until around 1990. The two leaders reviewed their work magisterially in 1988 (46), acknowledging a special debt to R. M. Adlington. In the early years these funds received revenue from Abraham and Newton's work, which of course ran out when the patents did; they now receive only investment income. For 30 years Abraham was able to take a close interest in the funds, which made general support grants, endowed professorships, funded research fellowships, and enabled many eponymous building projects. This work continues on an increasing scale. Despite massive support of their prescribed objectives from the outset, and which is ongoing (in 2011-12 totalling over £5 million, which might have been a below-average year), the three funds now have between them a capital base of well over £150 million. honours Abraham was honoured with a CBE, a knighthood (figure 1), the Royal Society Royal and Mullard Medals, the Scheele Medal of the Swedish Pharmaceutical Society, honorary doctorates from at least four universities, and honorary fellowships of at least seven Oxford colleges. He was a Foreign Honorary Member of the American Academy of Arts and Science, and a Kentucky Colonel. He accepted the adulation accorded him as the elder statesman and philanthropist of the world of antibiotics with modesty and courtesy, but in time he became embarrassed, and he declined with apology at least one Oxford honorary fellowship. He was nominated for a share in a Nobel prize in 1981, apparently without his knowledge, and again in 1983; when approached in 1996 he was gracefully evasive.
posTwar personal life
A student who joined Abraham at the Dunn School soon after Newton's premature death in 1969, which was a great personal as well as professional loss to Abraham, writes: I have very happy and positive memories of my student days with EPA, as he was known. The group was busy and highly productive. Although in my day I never remember him doing any serious 'hands on' bench work, he was very attuned to his students' projects and was rigorous in his scientific approach to them. His students received much insightful encouragement, but at the same time he expected 100% commitment from them.
After the war, Florey, a Fellow of Lincoln College, obtained a benefaction from Lord Nuffield to establish fellowships at Lincoln commemorating the penicillin work. Abraham was elected to a non-voting Nuffield (Penicillin) Research Fellowship in 1948. He enjoyed participating in college life, and played an active role on the college's governing body (especially its finance committee) from 1960, when he was elected to a professorial fellowship with full voting rights. As he was elected to an honorary fellowship when he retired, his close connection to Lincoln continued for the rest of his life. His affection for it is amply demonstrated by the fact that he set up the first and largest of his Trust Funds so that Lincoln would be especially favoured and the Rector of Lincoln was a Trustee ex officio.
He seems to have enjoyed the affectionate respect of all who knew him, and even got on well with Chain, a volatile and difficult character who fell out with most of his colleagues. Abraham retired from his university post at the then statutory age of 67 years in 1980, but was active in the Dunn School and a great traveller to international conferences for another decade or so. And the regular visits to Norway (usually three weeks at Easter, six weeks in the summer) with Asbjørg, which had been a major part of their lives since soon after the war, continued until 1994.
In retirement (figure 2) he had more time to act on the gratitude he felt to KES for his start in life (Darby 2004 ). President of the Old Edwardians for many years, he made numerous visits with Asbjørg, and they became friends of successive Heads. When in 1977 the Governors were facing the need to decide between independence and fitting into a state system in which selective admission by academic ability was frowned on, Abraham had written out of the blue to offer to give major assistance through the EPA Cephalosporin Fund if the school became independent, and this he did. New laboratories were funded, and scholarships and bursaries in chemistry and biology for sixth-formers joining from the state-maintained sector were established. In 1985 he became Patron of a KES Appeal, and in commending it he wrote, 'When I was myself a pupil at the School I was impressed by the opportunities it offered to boys from a wide range of family backgrounds, many of them by no means wealthy', and continued that he was proud to have played his part in helping 'to keep the school open to pupils of limited means'.
But from around 1990 the Abrahams mostly lived in quiet retirement at Badgers Wood, the substantial Boars Hill house and garden just outside Oxford which they loved. The house was in fact almost the only outward sign of wealth; he bought a nice car in 1984, but it aged with him, and he still owned it when he died. He had a serious bout of Guillain-Barré syndrome in 1993, and joked when he came out of hospital that, having ridden his bike into the Cherwell and survived the resulting Weil's disease many years before, he had beaten not one but two rare diseases. His last scientific paper (49) We are heavily indebted to those who catalogued Abraham's very extensive papers in the Bodleian Library, and to the summary of his life and work that opens the catalogue. He prepared a few autobiographical notes for the Royal Society, which survive in the Bodleian Abraham Papers at A.1, and his many historical notes, forewords, book reviews, conference introductions, biographical memoirs and suchlike are, no doubt unintentionally, often partly autobiographical. The long video interview that he recorded under the auspices of the Biochemical Society in 1990 was also very illuminating.
We also found three biographies of Howard Florey (Bickel 1972; Macfarlane 1979; Williams 1984) 
